Skip to main content

Table 1 Patient information, tumour volume and cavity surface

From: Phenol levels during intralesional curettage and local adjuvant treatment of benign and low-grade malignant bone tumours

Patient

Age/Gender

PA

Location

Tumour volume (cm3)

Cavity surface (cm2)

1

41/M

CHS I

Proximal humerus

27

73,4

2

39/M

CHS I

Distal femur

48,1

74,2

3

40/F

CHS I

Distal tibia

9,2

24,6

4

411 M

CHS I

Proximal humerus

26,3

62,3

5

45/F

CHS I

Proximal humerus

40,8

72,6

6

70ff

CHS I

Distal femur

10,9

62,3

7

55/M

CHS I

Distal femur

39,4

74,6

8

59/F

CHS I

Proximalhumerus

14,7

33,4

9

49/F

CHS II

Proximal humerus

9,7

25,8

10

48/F

CHS I

Distal femur

33

58,8

11

67/F

CHS I

Distal tibia

5,2

16,8

12

44/F

CHS I

Proximal humerus

25,8

49,4

13

33/NI

CHS I

Metacarpal

V 4,4

15,3

14

50/F

CHS I

Humerus

44

74,5

15

55/F

CHS I

Proximal humerus

32

59,3

16

26/F

CHS I

Distal femur

20

51,5

  1. Characteristics of the 16 patients where the tests during surgery were performed. Depending on the location of the chondrosarcoma, the cavity surface varies.